Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery
|
April 23, 2026
Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma
Ryan T Morse, Ying Cao, Victoria Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2020
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
Bhishamjit S Chera, Sunil Kumar, Colette Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2019
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S Chera, Robert J Amdur, Rebecca Green, et al.
British Journal of Cancer
|
June 30, 2018
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Ranee Mehra, Tanguy Y Seiwert, Shilpa Gupta, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer
David E Kozono, Thomas E Stinchcombe, Joseph K Salama, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT Carcinoma
Jeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2019
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort
Neil H Segal, Sai-Hong I Ou, Ani Balmanoukian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q M Chow, Robert Haddad, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Bhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
JAMA Otolaryngology-- Head & Neck Surgery
|
April 23, 2026
Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma
Ryan T Morse, Ying Cao, Victoria Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2020
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
Bhishamjit S Chera, Sunil Kumar, Colette Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2019
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S Chera, Robert J Amdur, Rebecca Green, et al.
British Journal of Cancer
|
June 30, 2018
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Ranee Mehra, Tanguy Y Seiwert, Shilpa Gupta, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer
David E Kozono, Thomas E Stinchcombe, Joseph K Salama, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT Carcinoma
Jeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2019
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort
Neil H Segal, Sai-Hong I Ou, Ani Balmanoukian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q M Chow, Robert Haddad, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Bhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.
Page
of 10